Growth Metrics

Cryoport (CYRX) EPS (Weighted Average and Diluted) (2019 - 2026)

Cryoport has reported EPS (Weighted Average and Diluted) over the past 11 years, most recently at -$0.23 for Q1 2026.

  • Quarterly EPS (Weighted Average and Diluted) rose 17.86% to -$0.23 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.67 through Mar 2026, up 263.11% year-over-year, with the annual reading at $1.4 for FY2025, 161.14% up from the prior year.
  • EPS (Weighted Average and Diluted) was -$0.23 for Q1 2026 at Cryoport, down from $2.03 in the prior quarter.
  • Over five years, EPS (Weighted Average and Diluted) peaked at $2.05 in Q2 2025 and troughed at -$1.62 in Q2 2024.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.24 (2022), against an average of -$0.13.
  • The largest YoY upside for EPS (Weighted Average and Diluted) was 620.51% in 2025 against a maximum downside of 550.0% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.24 in 2022, then crashed by 450.0% to -$1.32 in 2023, then surged by 70.45% to -$0.39 in 2024, then surged by 620.51% to $2.03 in 2025, then plummeted by 111.33% to -$0.23 in 2026.
  • Per Business Quant, the three most recent readings for CYRX's EPS (Weighted Average and Diluted) are -$0.23 (Q1 2026), $2.03 (Q4 2025), and -$0.18 (Q3 2025).